Proteomic Analysis of Urinary Extracellular Vesicles Reveals a Role for the Complement System in Medullary Sponge Kidney Disease.
complement system
idiopathic calcium nephrolithiasis
medullary sponge kidney
proteomics
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
05 Nov 2019
05 Nov 2019
Historique:
received:
12
09
2019
revised:
15
10
2019
accepted:
04
11
2019
entrez:
8
11
2019
pubmed:
7
11
2019
medline:
31
3
2020
Statut:
epublish
Résumé
Medullary sponge kidney (MSK) disease is a rare and neglected kidney condition often associated with nephrocalcinosis/nephrolithiasis and cystic anomalies in the precalyceal ducts. Little is known about the pathogenesis of this disease, so we addressed the knowledge gap using a proteomics approach. The protein content of microvesicles/exosomes isolated from urine of 15 MSK and 15 idiopathic calcium nephrolithiasis (ICN) patients was investigated by mass spectrometry, followed by weighted gene coexpression network analysis, support vector machine (SVM) learning, and partial least squares discriminant analysis (PLS-DA) to select the most discriminative proteins. Proteomic data were verified by ELISA. We identified 2998 proteins in total, 1764 (58.9%) of which were present in both vesicle types in both diseases. Among the MSK samples, only 65 (2.2%) and 137 (4.6%) proteins were exclusively found in the microvesicles and exosomes, respectively. Similarly, among the ICN samples, only 75 (2.5%) and 94 (3.1%) proteins were exclusively found in the microvesicles and exosomes, respectively. SVM learning and PLS-DA revealed a core panel of 20 proteins that distinguished extracellular vesicles representing each clinical condition with an accuracy of 100%. Among them, three exosome proteins involved in the lectin complement pathway maximized the discrimination between MSK and ICN: Ficolin 1, Mannan-binding lectin serine protease 2, and Complement component 4-binding protein β. ELISA confirmed the proteomic results. Our data show that the complement pathway is involved in the MSK, revealing a new range of potential therapeutic targets and early diagnostic biomarkers.
Identifiants
pubmed: 31694344
pii: ijms20215517
doi: 10.3390/ijms20215517
pmc: PMC6862015
pii:
doi:
Substances chimiques
Proteins
0
Complement System Proteins
9007-36-7
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Déclaration de conflit d'intérêts
The authors have no conflict of interest to declare.
Références
AJR Am J Roentgenol. 1985 Aug;145(2):315-9
pubmed: 3895858
J Med Case Rep. 2018 Jul 9;12(1):197
pubmed: 29983117
Dev Dyn. 2000 Jun;218(2):213-34
pubmed: 10842354
Methods Mol Biol. 2018;1678:79-92
pubmed: 29071676
J Immunol. 2011 May 15;186(10):5815-22
pubmed: 21490156
J Immunol. 2010 Dec 1;185(11):6899-910
pubmed: 21037097
Scanning Microsc. 1996;10(2):415-23; 423-4
pubmed: 9813620
J Cell Sci. 2006 Oct 1;119(Pt 19):4047-58
pubmed: 16968749
Urolithiasis. 2017 Aug;45(4):359-362
pubmed: 27573101
Immunobiology. 2008;213(3-4):297-306
pubmed: 18406375
J Am Soc Nephrol. 2016 Oct;27(10):3079-3092
pubmed: 26940098
Nephron Physiol. 2004;98(2):p43-7
pubmed: 15499214
World J Nephrol. 2015 May 6;4(2):169-84
pubmed: 25949931
J Leukoc Biol. 2011 Sep;90(3):425-37
pubmed: 21730084
J Am Soc Nephrol. 2002 May;13(5):1210-8
pubmed: 11961008
J Med Case Rep. 2009 Apr 29;3:6656
pubmed: 19830120
Nephrol Dial Transplant. 2013 May;28(5):1111-9
pubmed: 23229933
Clin J Am Soc Nephrol. 2019 Jun 7;14(6):834-843
pubmed: 31018934
Ann N Y Acad Sci. 1995 Apr 21;760:375-7
pubmed: 7785921
Mol Immunol. 2009 Sep;46(15):2902-10
pubmed: 19660812
Nucleic Acids Res. 2017 Jan 4;45(D1):D833-D839
pubmed: 27924018
J Am Soc Nephrol. 1996 Aug;7(8):1123-30
pubmed: 8866402
J Intern Med. 2014 Nov;276(5):470-85
pubmed: 24494798
Int J Mol Sci. 2016 May 24;17(6):
pubmed: 27231899
Kidney Int. 2017 Feb;91(2):459-468
pubmed: 27914711
Mol Immunol. 2009 Dec;47(2-3):215-21
pubmed: 19853918
Nephrol Dial Transplant. 2005 Jun;20(6):1042-7
pubmed: 15814540
Mol Immunol. 2007 Sep;44(16):3875-88
pubmed: 17768106
Proteomics Clin Appl. 2008 Jul 1;2(7-8):1140-1152
pubmed: 20411046
Kidney Int. 2001 Dec;60(6):2087-96
pubmed: 11737583
Br J Urol. 1988 May;61(5):392-4
pubmed: 3395796
J Biol Chem. 2006 Sep 29;281(39):29181-9
pubmed: 16870608
J Am Soc Nephrol. 2006 Jul;17(7):1913-22
pubmed: 16790509
Urology. 1987 Apr;29(4):426-7
pubmed: 3564218
Am J Physiol Renal Physiol. 2014 Mar 15;306(6):F640-54
pubmed: 24370592
Clin Proteomics. 2012 Dec 11;9(1):13
pubmed: 23228063
Clin J Am Soc Nephrol. 2009 Dec;4(12):1974-9
pubmed: 19808216
Urology. 2012 Feb;79(2):277-81
pubmed: 22014971
Mass Spectrom Rev. 2011 Nov-Dec;30(6):1185-202
pubmed: 21544848
J Am Soc Nephrol. 2012 Jul;23(7):1161-71
pubmed: 22518005
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13368-73
pubmed: 15326289